Investors / United States / Unorthodox Ventures
Unorthodox Ventures
Venture capital · Austin, TX, United States · North America
Unorthodox Ventures is a venture capital firm with a single LP that makes investing decisions quickly and focuses on long-term success. It invests in startups around the world, often helping overseas companies open their first American offices, and provides operational support in areas such as PR, manufacturing and go-to-market modeling.
Invests inHealthcare & Biotech
In its own wordsmedtechhealthcaremedical devicesoperational supportglobal
Your fit with Unorthodox Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsUnorthodox Ventures lists 23 checked portfolio companies on its own site and is named in 5 funding rounds. Its most frequent entry is Series B, 60% of the companies with a known first round. Its largest themes are Healthcare & Biotech (67%), Industrial & Manufacturing (11%) and AI & Machine Learning (7%). 55% of its companies are based in United States. It invests most often alongside 415 Capital, AMED Ventures and A-Level Capital.
Counts come from funding rounds that name Unorthodox Ventures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Unorthodox Ventures' whole history. Rounds on record name 5 companies; its own site lists 23. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundUnorthodox Ventures does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 20% |
| Series A | 20% |
| Series B | 60% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 1 | 0 |
| '25 | 1 | 0 |
| '26 | 3 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 57th | 23 companies |
| Recent activity | 76th | 3 rounds in 12 months |
| Early stage | 58th | 20% of entries at pre-seed or seed |
| Evidence | 89th | 17% of companies confirmed by a round |
| Sector focus | 91th | 67% in its largest sector |
| Reach | 91th | 8 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| 415 Capital | 3 |
| AMED Ventures | 3 |
| A-Level Capital | 1 |
| Aescuvest | 1 |
| Aphelion Capital | 1 |
| Argonautic Ventures | 1 |
| Asahi Kasei Ventures | 1 |
| Auxxo | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers23100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 67% | 15% |
| Industrial & Manufacturing | 11% | 7% |
| AI & Machine Learning | 7% | 18% |
| Real Estate & Construction | 4% | 3% |
| Fintech | 4% | 12% |
| Food & Agriculture | 4% | 3% |
| Consumer | 4% | 3% |
Co-investor network
who it backs companies with, and who they back togetherCompare Unorthodox Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Unorthodox Ventures| Date | Company | Stage |
|---|---|---|
| 4 Nov 2026 | Series B | |
| 29 Sept 2026 | Series A | |
| 11 May 2026 | Seed | |
| 3 Oct 2025 | Series B | |
| 10 Sept 2024 | Series B |
Round details for Unorthodox Ventures
Amounts, full round histories and every co-investor in Unorthodox Ventures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
23 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Afia makes frozen Eastern Mediterranean foods from scratch with whole food ingredients | Food & Agriculture | Portfolio page | ||
| Akura Medical develops medical devices for treating venous thromboembolism | Healthcare & Biotech | Oct 2025Series B | Page + round | |
| Carthera develops innovative ultrasound-based medical devices to treat brain disorders | Healthcare & Biotech | Portfolio page | ||
| ConKay Medical Systems is an early stage medical device company advancing solutions to treat valvular regurgitation in patients with progressive heart failure. | Healthcare & Biotech | Portfolio page | ||
| Corflow develops solutions for detecting and treating microvascular disease, specifically microvascular obstruction in heart attack patients. | Healthcare & Biotech | Sept 2024Series B | Page + round | |
| Corporis Medical is a medical device company dedicated to developing and commercializing innovative healthcare solutions. | Healthcare & Biotech | Portfolio page | ||
| DiaMonTech develops non-invasive blood glucose measurement technologies | Healthcare & Biotech | Portfolio page | ||
| Lumen develops glasses that replicate the main features of a guide dog for the visually impaired | Healthcare & BiotechAI & Machine Learning | Portfolio page | ||
| Elucid offers a clinical platform for non-invasive CT plaque analysis for cardiologists and radiologists | Healthcare & Biotech | Portfolio page | ||
| Exero Medical develops a system to detect post-operative complications, such as anastomotic leaks, using tissue healing data | Healthcare & Biotech | Portfolio page | ||
| Firmus analyzes construction drawings to identify and mitigate risks early, reducing the chance of costly mistakes and disputes. | AI & Machine LearningReal Estate & Construction | Portfolio page | ||
| Genda provides a multi-purpose field app to help construction companies manage their workforce, safety, and logistics | ConsumerIndustrial & Manufacturing | Portfolio page | ||
| TUSHY sells bidets and related products | Healthcare & Biotech | Portfolio page | ||
| Inovus Medical helps surgeons train faster and better through purposeful practice with various products and solutions. | Healthcare & Biotech | Sept 2026Series A | Page + round | |
| KEWAZO develops robotics and AI for industrial maintenance and construction | Industrial & Manufacturing | Portfolio page | ||
| Laplace Interventional is developing a Transcatheter tricuspid valve replacement system | Healthcare & Biotech | Portfolio page | ||
| Laza Medical is developing an intelligent imaging system to simplify cardiac procedures | Healthcare & Biotech | Nov 2026Series B | Page + round | |
| Third Pole Therapeutics develops inhaled nitric oxide therapy devices | Healthcare & Biotech | Portfolio page | ||
| Sonavex provides automated 3D ultrasound solutions designed for the dialysis access care team, enabling members to quantify and visualize critical clinical data to improve patient care. | Healthcare & Biotech | Portfolio page | ||
| Supira Medical is developing a next-generation percutaneous ventricular assist device for use in high-risk patients undergoing interventional procedures or experiencing cardiogenic shock. | Healthcare & Biotech | Portfolio page |
About this data
site last read 8 Nov 2026- Site
- unorthodoxventures.com
- Last read
- 8 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 10 Sept 2024
- Companies checked
- 23
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Unorthodox Ventures' profile as data
Pull Unorthodox Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/unorthodoxventures.com
# also
GET /v1/firms/unorthodoxventures.com/portfolio
GET /v1/firms/unorthodoxventures.com/coinvestors
GET /v1/firms/unorthodoxventures.com/news